About Verde Science

Verde Science (VRCI-OTCQB) has assembled an impressive team of scientists from highly technical disciplines including Bioprocess Technology, Nanotechnology, Molecular Virology and Immunology, Molecular Biology, Pharmacology and Medical Device Design. Our focus is the discovery of novel drugs and new treatment modalities, as well as cutting edge diagnostic devices and pharmaceutical delivery systems for the treatment of emerging diseases and contemporary medical issues where current treatments either do not exist or are inadequate.

An initial focus is on developing custom medicinal formulations from cannabinoids and THC compounds for the treatment of specific issues such as migraines, glaucoma, loss of appetite from cancer therapies, and numerous other medical issues. Verde also plans to alpha test innovative growing technologies in India as part of the company’s initiatives.

Verde Science’s Research and Development Program
Currently the company is working on starting a Research and Development initiative in Canada upon becoming licenced. In the meantime, the company is beginning a THC Pharmaceutical Development Program to be run through its alliance with the Institute of Chemical Technology in Mumbai, India. The program will include executing comprehensive research to develop specific, custom formulations and novel delivery mechanisms for cannabinoid and THC based drugs.

Verde Science’s Mission
Engaging in innovative research and development to isolate cost-effective pharmacological formulations and novel delivery technologies to treat emerging diseases and contemporary medical issues.